Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.
about
Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Imatinib in systemic mastocyto ...... and review of the literature.
@en
type
label
Imatinib in systemic mastocyto ...... and review of the literature.
@en
prefLabel
Imatinib in systemic mastocyto ...... and review of the literature.
@en
P2093
P2860
P356
P1433
P1476
Imatinib in systemic mastocyto ...... s and review of the literature
@en
P2093
Alberto Orfao
Almudena Matito
Andrea Mayado
Carolina Caldas
Cristina Teodósio
Iván Alvarez-Twose
Javier Ignacio Muñoz-González
José Mário Morgado
Luis Escribano
Manuela Mollejo
P2860
P356
10.18632/ONCOTARGET.10711
P407
P577
2016-07-19T00:00:00Z